Clotting Disorders

Clotting Disorders

A collection of features and news articles published in ASH Clinical News related to clotting disorders.

You Make the Call

Reader Responses: How long should a young patient with COVID-19 and pulmonary embolism receive...

Here’s how readers responded to a You Make the Call question about anticoagulation for a young patient with COVID-19 and pulmonary embolism. Disclaimer: ASH does...
You Make the Call

You Make the Call: How long should a young patient with COVID-19 and pulmonary...

This month, Caroline Berube, MD, discusses anticoagulation for a young patient with COVID-19 and pulmonary embolism. And don't forget to check out next month's clinical...
How I Treat In Brief

How I Treat Venous Thromboembolism in Pregnancy

Saskia Middeldorp, MD, PhD, and Wessel Ganzevoort, MD, PhD, discuss the diagnosis, treatment, and prevention of venous thromboembolism in pregnant women. This material is...

Benefits of AstraZeneca’s COVID-19 Vaccine Outweigh Clotting Risk, Regulatory Agencies Say

Following reports of an unusual increase in cerebral sinus venous blood clots and one death associated with the COVID-19 vaccine developed by AstraZeneca and...
On location

Testing for Inherited Thrombophilias Provides Limited Benefit

Inherited thrombophilias are associated with an increased risk of initial and recurrent venous thromboembolism (VTE), but testing for these conditions in the setting of...

Can Patients Safely Continue Estrogen During Gender-Affirming Surgery?

Discontinuing estrogen hormone therapy before gender-affirming surgery is not necessary, according to findings published in the Journal of Clinical Endocrinology and Metabolism. As estrogen and...

NIH’s ACTIV Trial Suspends Enrollment of Critically Ill Patients With COVID-19

The National Institutes of Health (NIH) announced that it is pausing enrollment of patients with severe COVID-19 in three trials that are evaluating anticoagulants...
WIB_icon

Is Caplacizumab a Cost-Effective Strategy for Acquired TTP?

In February 2019, the FDA approved the anti–von Willebrand factor immunoglobulin fragment caplacizumab as the only agent specifically indicated for the treatment of adults...
On location

In Utero Hematopoietic Cell Transplantation Safe in Fetuses with Alpha Thalassemia Major

In utero hematopoietic cell transplantation (IUHCT) with maternal cells was safe in two fetuses with alpha thalassemia major (ATM), according to interim results of...

Normal Results on D-Dimer Testing Can Safely Rule out Deep Vein Thrombosis

A simplified approach of an initial stand-alone D-dimer test followed by a single whole-leg compression ultrasound (CUS) in D-dimer positive patients can effectively and...
Advertisement

Current Issue

April 2021 Volume 7 Issue 5

This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.

Block title